Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparable actions of omalizumab on mast cells and basophils.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology - 1 Jan 2016

Serrano-Candelas E, Martinez-Aranguren R, Valero A, Bartra J, Gastaminza G, Goikoetxea M J, Martín M, Ferrer M

Abstract excerpt

BACKGROUND: Omalizumab (OmAb) has recently been approved for the treatment of diseases other than allergic asthma, including chronic urticaria. The exploration of the use of OmAb in chronic urticaria was based on the presence of IgE autoantibodies against autoantigens such as anti-IgE, anti-FcεRI, and IgE antibodies against thyroid peroxidase in certain patients with chronic urticaria. OmAb recognizes and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Basophils
Share to Endocytosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunoglobulin E

Share to Immunoglobulin G

Share to Immunophenotyping

Share to Mast Cells

Share to Receptors, Antigen, B-Cell

Share to Receptors, IgE

Source

Identifiers

PMID: 26509363
DOI: 10.1111/cea.12668

Genes

LAT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparable actions of omalizumab on mast cells and basophils.PMID 26509363Read ↗

Remibrutinib inhibits human mast cell and basophil activation induced by serum from Chronic Urticaria patients independently of FcεR1 expressionSemantic proximity Read ↗

The anti-IgE mAb omalizumab induces adverse reactions by engaging Fcγ receptors.Semantic proximity Read ↗

Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange.Semantic proximity Read ↗

Influence of effective omalizumab treatment on eosinophils in allergic asthma with comorbiditiesSemantic proximity Read ↗

Structural and Functional Insights Into IgE Receptor Interactions and Disruptive InhibitionSemantic proximity Read ↗

Structural and Physical Basis for Anti-IgE Therapy.Semantic proximity Read ↗

A fully human anti-c-Kit monoclonal antibody 2G4 inhibits proliferation and degranulation of human mast cellsSemantic proximity Read ↗

Combined analytical assays for the characterization of drugs binding to human IgE: Applicability to omalizumab-bearing biosimilar candidates assessmentSemantic proximity Read ↗

Morin inhibits Fyn kinase in mast cells and IgE-mediated type I hypersensitivity response in vivoSemantic proximity Read ↗

Omalizumab reverses the phenotypic and functional effects of IgE-enhanced Fc epsilonRI on human skin mast cells.Semantic proximity Read ↗

Omalizumab in the Treatment of Hyper-IgE Syndrome: 2 Case Reports.Semantic proximity Read ↗

Accelerated disassembly of IgE-receptor complexes by a disruptive macromolecular inhibitor.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.